Iradimed (IRMD) Earnings Date
The next earnings date for Iradimed (IRMD) is expected by Feb 8, 2027, per the data provider's calendar.
- Next earnings date
- Feb 8, 2027
- expected by · quarter ending Dec '26
- Consensus EPS
- $0.59
- Dec '26 quarter · 2 analysts
- Consensus revenue
- $25.4M
- Dec '26 quarter · 3 analysts
- Latest stored quarter
- EPS 0.51
- revenue $24.2M · reported Oct 30, 2026
Does this company deliver against its own promises? Earnings are a check on the thesis, not a catalyst to chase.
0 of 2 scored quarters beat.
| Report | Est EPS | Act EPS | Surprise | Est rev | Act rev | Rev surp. | Reaction |
|---|---|---|---|---|---|---|---|
| Oct 30, 20268-K, before open · 8:30 am ET | 0.55 | 0.51 | −7.3% | $23.5M | $24.2M | +3.1% | −10.6%release day |
| Jul 31, 2026 filed | 0.44 | 0.41 | −6.8% | $20.4M | $20.5M | +0.6% | —filing date only |
| May 1, 20268-K, before open · 8:45 am ET | — | 0.45 | — | — | $22.0M | — | +4.4%release day |
| Feb 10, 20268-K, before open · 8:00 am ET | — | 0.50 | — | — | $22.7M | — | +9.6%release day |
| Nov 3, 20258-K, before open · 8:30 am ET | — | 0.43 | — | — | $21.2M | — | +9.5%release day |
| Aug 1, 20258-K, before open · 8:32 am ET | — | 0.45 | — | — | $20.4M | — | +13.4%release day |
| May 5, 20258-K, before open · 7:00 am ET | — | 0.37 | — | — | $19.5M | — | −2.2%release day |
| Feb 13, 20258-K, before open · 8:30 am ET | — | 0.40 | — | — | $19.4M | — | −8.4%release day |
Estimate-vs-actual scoring began Jul 2026 and is still accruing: 2 of the 8 quarters above carry a scored estimate. We never backfill an estimate we didn't observe.
filed marks a quarter where we found no results release and hold only the date its report was filed. A filing can trail the release by days or weeks, so those rows show no reaction rather than the move of an unrelated session.
| Measure | Dec '26 | Mar '27 | FY26 | FY27 |
|---|---|---|---|---|
| No. of analysts | 2 | 3 | 2 | 2 |
| Avg estimate | 0.59 | 0.58 | 2.10 | 2.44 |
| Low estimate | 0.57 | 0.56 | 2.07 | 2.42 |
| High estimate | 0.61 | 0.61 | 2.12 | 2.45 |
| Year-ago EPS | 0.50 | 0.45 | 1.75 | 2.10E |
| Implied growth | +18.7% | +28.9% | +19.8% | +16.2% |
| Measure | Dec '26 | Mar '27 | FY26 | FY27 |
|---|---|---|---|---|
| No. of analysts | 3 | 2 | 2 | 2 |
| Avg estimate | $25.4M | $24.7M | $92.2M | $102.3M |
| Low estimate | $24.8M | $23.9M | $91.7M | $101.8M |
| High estimate | $25.9M | $25.6M | $92.7M | $102.9M |
| Year-ago revenue | $22.7M | $22.0M | $83.8M | $92.2ME |
| Implied growth | +11.8% | +12.5% | +10.0% | +11.0% |
| Snapshot age | Dec '26, period ending Dec 30, 2026 | Mar '27, period ending Mar 30, 2027 | FY26, period ending Dec 31, 2026 | FY27, period ending Dec 31, 2027 |
|---|---|---|---|---|
| Current estimate | 0.59 | 0.58 | 2.10 | 2.44 |
| 7 days ago | 0.59 | — | 2.10 | 2.44 |
| 30 days ago | 0.63 | — | 2.11 | 2.45 |
| 60 days ago | 0.62 | — | 2.09 | 2.41 |
| 90 days ago | 0.61 | — | 2.09 | 2.41 |
Estimate history accrues from our nightly snapshots. The 7/30/60/90-day rows fill in as tracking continues. Each column follows one fiscal period back through our snapshots; a dash means we had not recorded that period at that age. A rising bar makes a beat streak more meaningful; a falling one manufactures beats.
Dec '26 quarter consensus moved $0.61 → $0.59 over 90 tracked days, the same quarter at both ends. Per-analyst up/down revision counts aren't in our data feed. We show the bar's actual movement instead of guessing.
Common questions
When does Iradimed report earnings next?
Iradimed's next earnings date is expected by Feb 8, 2027, per the data provider's calendar.
What were Iradimed's latest quarterly earnings?
Iradimed reported diluted EPS of 0.51 and revenue of $24.2M on Oct 30, 2026.
How did Iradimed's stock move after its last earnings report?
Iradimed moved −10.6% in the session after its Oct 30, 2026 report.

